Dosing and Administration

Top banner braf

BRAFTOVI + cetuximab dosing and administration

BRAFTOVI 300 mg > 4 BRAFTOVI capsules (75 mg each)  + Cetuximab Initial dose: 400 mg/m2 Subsequent dose: 250 mg/m2


  • Refer to the cetuximab Summary of Product Characteristics for additional information

Treatment with BRAFTOVI + cetuximab should be continued until disease progression or unacceptable toxicity1

  • Instruct patients not to take a missed dose of BRAFTOVI within 12 hours of the next dose
  • In case of vomiting after taking BRAFTOVI, patients must not take an additional dose and should resume dosing with the next scheduled dose


picto food  BRAFTOVI may be taken with or without food. Grapefruit juice
  should be avoided1


Braftovi - snowflake  No refrigeration requirement; instruct your patients to store
  BRAFTOVI below 30°C1

Download the Therapy Management Guide for more information on dosing and adverse reactions

Download the file

Thank you for the interest you give to our publications. Before accessing to our document, please tell us more about you.

HealthCare Professionals​

This is an international website for BRAFTOVI dedicated to Healthcare professionals ​​

IMPORTANT: the information on this website is based on the European Summary of Product Characteristics. Prescribing Information and indication may vary per country. You must refer to your country prescribing information. Please be aware we do not take responsibility for accessing such information which may not comply with the regulation or usage in your country.

I certify that:

I am Healthcare Professional outside the US and I have read the information above​. 


This is an international website for BRAFTOVI dedicated to Healthcare professionals.

I am a patient outside the US​